...
首页> 外文期刊>Journal of Medicinal Chemistry >Convergent Synthesis and Unexpected Ca~(2+)-Mobilizing Activity of 8-Substituted Analogues of Cyclic ADP-Carbocyclic-Ribose, a Stable Mimic of the Ca~(2+)-Mobilizing Second Messenger Cyclic ADP-Ribose
【24h】

Convergent Synthesis and Unexpected Ca~(2+)-Mobilizing Activity of 8-Substituted Analogues of Cyclic ADP-Carbocyclic-Ribose, a Stable Mimic of the Ca~(2+)-Mobilizing Second Messenger Cyclic ADP-Ribose

机译:环合成ADP-碳环核糖的8个类似物的聚合合成和意想不到的Ca〜(2+)活化活性,这是Ca〜(2+)活化的第二信使环ADP核糖的稳定模拟物。

获取原文
获取原文并翻译 | 示例
           

摘要

Cyclic ADP-carbocyclic-ribose (cADPcR, 2) is a biologically and chemically stable equivalent of cyclic ADP-ribose (cADPR, 1), a Ca~(2+)-mobilizing second messenger. In this study, a series of 8-substituted analogues of cADPcR, namely the 8-chloro analogue 6 (8-Cl-cADPcR), the 8-azido analogue 7 (8-N_3-cADPcR), the 8-amino analogue 8 (8-NH_2-cADPcR), and the 8-phenylthio analogue 9 (8-SPh-cADPcR), were designed as effective pharmacological tools for studies on cADPR-modulated Ca~(2+) signaling pathways. These target compounds were synthesized by a convergent route via 8-Cl-cADPcR bisacetonide (14) as the common intermediate, in which a method for forming the intramolecular pyrophosphate linkage by activation of the phenylthiophosphate type substrate 15 with AgNO_3 to produce 14 was used as the key step. The carbocyclic analogues were tested for activity in the sea urchin egg homogenate system. Compounds were assessed for their calcium-mobilizing effects and their ability to cross-desensitize with calcium release induced by a normally maximal concentration of cADPR, as well as cADPR antagonism of cADPR-evoked calcium release. While cADPcR was 3-4 times more potent than cADPR, the 8-substituted analogues were less efficacious, with 8-SPh-cADPcR largely acting as a competitive antagonist. Most surprisingly, given that 8-N_3-cADPR and 8-NH_2-cADPR are known as potent antagonists, 8-N_3-cADPcR and 8-NH_2-cADPcR were full agonists, but ca. 80 and 2 times less potent than cADPR, respectively. These data contribute to developing structure-activity relationships for the interaction of cADPR with its receptor.
机译:环状ADP-碳环核糖(cADPcR,2)是可动化Ca〜(2+)的第二信使环状ADP-核糖(cADPR,1)的生物学和化学稳定等价物。在这项研究中,一系列cADPcR的8位取代类似物,即8-氯类似物6(8-Cl-cADPcR),8位叠氮基类似物7(8-N_3-cADPcR),8位氨基类似物8​​( 8-NH_2-cADPcR)和8-苯硫基类似物9(8-SPh-cADPcR)被设计为有效的药理工具,用于研究cADPR调节的Ca〜(2+)信号通路。通过8-Cl-cADPcR双丙酮化物(14)通过收敛途径合成这些目标化合物,其中使用通过用AgNO_3活化苯基硫代磷酸酯型底物15以产生14而形成分子内焦磷酸酯键的方法。关键步骤。测试了碳环类似物在海胆卵匀浆系统中的活性。评估化合物的钙动员作用,以及对正常最大浓度的cADPR诱导的钙释放交叉脱敏的能力,以及cADPR引起的钙释放引起的cADPR拮抗作用。尽管cADPcR的效力是cADPR的3-4倍,但8-取代的类似物的疗效较差,而8-SPh-cADPcR在很大程度上是竞争性拮抗剂。最令人惊奇的是,已知8-N_3-cADPR和8-NH_2-cADPR被认为是有效的拮抗剂,8-N_3-cADPcR和8-NH_2-cADPcR是完全激动剂,但大约是。效力分别比cADPR低80倍和2倍。这些数据有助于发展结构-活性关系,以促进cADPR与其受体的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号